Why Teladoc Health, Inc.’s (TDOC) Stock Is Down 5.51%

By Jenna Brashear
July 31, 2026
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Teladoc Health, Inc. before investing.

In this article, we go over a few key elements for understanding Teladoc Health, Inc.’s stock price such as:

  • Teladoc Health, Inc.’s current stock price and volume
  • Why Teladoc Health, Inc.’s stock price changed recently
  • Upgrades and downgrades for TDOC from analysts
  • TDOC’s stock price momentum as measured by its relative strength

About Teladoc Health, Inc. (TDOC)

Before we jump into Teladoc Health, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, and mental health services, as well as technologies and enterprise telehealth solutions for hospitals and health systems. Its BetterHelp segment operates a mental health platform that provides online counselling and therapy services through websites, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc and BetterHelp brands. It serves employers, health plans, hospitals and health systems, insurance companies, and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in New York, New York.

Want to learn more about Teladoc Health, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Teladoc Health, Inc..

Learn More About A+ Investor

Teladoc Health, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Teladoc Health, Inc.’s stock price was $6.710.

Teladoc Health, Inc. is up 1.98% from its previous closing price of $6.580.

During the last market session, Teladoc Health, Inc.’s stock traded between $6.350 and $6.840. Currently, there are approximately 181.03 million shares outstanding for Teladoc Health, Inc..

Teladoc Health, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Teladoc Health, Inc. Stock Price History

Teladoc Health, Inc.’s (TDOC) price is currently down 20.87% so far this month.

During the month of July, Teladoc Health, Inc.’s stock price has reached a high of $9.890 and a low of $6.350.

Over the last year, Teladoc Health, Inc. has hit prices as high as $9.887 and as low as $4.400. Year to date, Teladoc Health, Inc.’s stock is down 4.14%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Teladoc Health, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were 0 analysts who downgraded Teladoc Health, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Teladoc Health, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Teladoc Health, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Teladoc Health, Inc.’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Teladoc Health, Inc. (TDOC) by visiting AAII Stock Evaluator.

Relative Price Strength of Teladoc Health, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Teladoc Health, Inc. has a weighted four-quarter relative price strength of -3.00%, which translates to a Momentum Score of 43 and is considered to be Average.

Want to learn more about how Teladoc Health, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Teladoc Health, Inc. Stock Price: Bottom Line

As of July 31, 2026, Teladoc Health, Inc.’s stock price is $6.710, which is up 1.98% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Teladoc Health, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
High Relative Dividend
Yield Screen:
8.7% Compared to S&P 500
at only 6.9%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.